Stories of Sekkei

Welcome to Sekkei Bio

Welcome to Sekkei Bio

Scaling up GenAI in Life Sciences, Galien Forum India, March 2024

Our co-founder Dr. Anirudh Ranganthan was part of the panel to discuss scaling up gen AI in in life sciences organized by the Galien Foundation in New Delhi.

Accenture Women Founders Program (WFP) India, Oct 2023

Our co-founder Dr. Monalisa Chatterji took part in the 2nd edition of Accenture Women Founders Program for the empowerment of woman founders & entrepreneurs organized by Accenture.

Sekkei Bio secures funding from BMGF for Global Health and Development Research, October 2023

To develop a proof of concept for a technology that would enable low-cost manufacturing process for the treatment of RSV/combination vaccines and other antigens.

Sekkei Bio secures funding from BMGF for Discovery and Translational Sciences Research, October 2023

To generate probe molecules to interrogate complex reproductive biology processes that could help further validate potential nonhormonal contraceptive targets.

Sekkei Bio among Top 10 Drug Research Companies 2023

India Pharma Outlook has featured Sekkei Bio as one of the top 10 Drug Discovery & Development Companies in India in 2023.

Adapting mRNA to Therapeutics Webinar, September 2022

Our founders Dr. Monalisa Chatterji, Dr. Anand Khedkar along with eminent RNA biologist Srivatsa Dwarakanath of the Max Planck Institute gave a talk through webinar conducted by Spinco Biotech.

Sekkei at Bio International Convention, July 13 -16, 2022

Dr. Anand Khedkar, one our co-founders participated at the prestigious Bio International Convention  in San Diego, USA.

COVID Moonshot: A Collaborative Approach to Antiviral Discovery, June 2022

Our co-founder Dr. Monalisa Chatterji along with Ed Griffen of MedChemica Ltd and Annette von Delft from University of Oxford, moderated a webinar on the COVID Moonshot consortium

Taking Novel Drugs from Lab to Clinic,7-11 March 2022

DNDi, the Indian Society for Clinical Research (ISCR), and BIRAC Regional Bio-Innovation Centre (a joint initiative of BIRAC and Venture Center) hosted a five day virtual workshop titled ‘Taking Novel Drugs from Lab to Clinic: Concepts and case Studies‘. Session was chaired by our founder Dr. Monalisa Chatterji.

She Is: 75 Women in STEAM March 2022

One of our founders Monalisa Chatterji was honoured as one among 75 Indian woman in STEAM (fields of Science, Technology, Engineering, Arts and Mathematics) on the occasion of India’s 75th Independence Day commemorations by the Office of the Principal Scientific Advisor to the Government of India in partnership with Red Dot Foundation, British High Commission, and FICCI FLO.

Sekkei Bio at Bengaluru Tech Summit 2020

Our co-founder Anirudh Ranganathan participated as a session panelist and delivered a  talk at Bengaluru Tech Summit-2020 (BTS-2020)

Sekkei Bio incubated and mentored at C-CAMP

C-CAMP has emerged as a thriving hub for innovation with a vibrant ecosystem. We have interacted with over 500 inventors and entrepreneurs and encouraged them to translate their inventions into innovation. Till date C-CAMP has supported over 100 start-ups/spin-offs through funding, bio-incubation and mentorship.

Sekkei Bio in the News, May 2018

Our co-founder Anand Khedkar spoke to The Economic Times on the emergence of a research and development ecosystem, along with early stage funding, being one of the reasons behind the birth of several deep-science companies and how it has helped Sekkei Bio in our research as well.

Sekkei Bio at CPHI Frankfurt 2022

Our founders took part at the CPhI 2022 in Frankfurt. CPhI is the world’s largest event for the pharmaceutical industry, it brings together more than 100,000 pharmaceutical professionals each year.

Sekkei Bio Connect

Scroll to Top